Infections in the immunocompromised rheumatologic patient

Critical Care Clinics

Volumn 18, Issue 4, 2002, Pages 931-956

  Greenberg, Stephen B ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b BEN TAUB GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTIBIOTIC AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOTOXIC AGENT; ETANERCEPT; HEPATITIS B VACCINE; IMMUNOSUPPRESSIVE AGENT; INACTIVATED VACCINE; INFLIXIMAB; MENINGOCOCCUS VACCINE; METHOTREXATE; PREDNISONE; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA;

ASPERGILLUS; CAPILLARY RESISTANCE; CLINICAL FEATURE; DISEASE PREDISPOSITION; DRUG HYPERSENSITIVITY; HAEMOPHILUS INFLUENZAE; HEPATITIS B VIRUS; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LYMPHOCYTOPENIA; MYCOBACTERIUM TUBERCULOSIS; MYCOSIS; NEISSERIA MENINGITIDIS; NEUTROPHIL CHEMOTAXIS; NEUTROPHILIA; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS CARINII; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; RHEUMATOID ARTHRITIS; SALMONELLA TYPHI; SIDE EFFECT; SKIN ATROPHY; STAPHYLOCOCCUS AUREUS; SYSTEMIC LUPUS ERYTHEMATOSUS; TUBERCULOSIS; VACCINATION; VIRUS INFECTION; WOUND HEALING IMPAIRMENT;

ADRENAL CORTEX HORMONES; ARTHRITIS, RHEUMATOID; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; INFECTION; INTENSIVE CARE UNITS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RHEUMATIC DISEASES;

EID: 0036839043     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0704(02)00022-2     Document Type: Review

References (311)

1. Al-Mayouf SM, Al-Jumaah S, Bahabri S, et al. Infections associated with juvenile systemic lupus erythematosus. Clin Exp Rheumatol 2001;19:748-50.
2. Ansell SM, Bedhesi S, Ruff B, et al. Study of critically ill patients with systemic lupus erythematosus. Crit Care Med 1996;24:981-4.
3. Baum J. Infection in rheumatoid arthritis. Arthritis Rheum 1971;14:135-7.
4. Bellomio V, Spindler A, Lucero E, et al. Systemic lupus erythematosus: Mortality and survival in Argentina. A multicenter study. Lupus 2000;9:377-81.
5. Bouza E, Moya JG, Munoz P. Infections in systemic lupus erythematosus and rheumatoid arthritis. Infect Dis Clin North Am 2001;15:335-61[vii.].
6. Buján S, Labrador M, Balada E, et al. Trends in mortality in a cohort of lupus patients [abstract]. Lupus 2001;10:S76.
7. Calabrese LH. Vasculitis of the central nervous system. Rheum Dis Clin North Am 1995;21:1059-76.
8. Corley DE, Winterbauer RH. Collagen vascular diseases. Semin Respir Infect 1995;10:78-85.
9. Cunha B. Infections in SLE. Infect Dis Clin Pract 1997;21:41-2.
10. Cunha BA. Infections in nonleukopenic compromised hosts (diabetes mellitus, SLE, steroids, and asplenia) in critical care. Crit Care Clin 1998;14;263-82.
11. Doran MF, Gabriel SE. Infections in rheumatoid arthritis - A new phenomenon? J Rheumatol 2001;28:1942-3.
12. Dubois EL, Tuffanelli DL. Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA 1964;190:104-11.
13. Duffy KN, Duffy CM, Gladman DD. Infection and disease activity in systemic lupus erythematosus: A review of hospitalized patients. J Rheumatol 1991;18:1180-4.
14. Fauci AS, Haynes BF, Katz P, et al. Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
15. Font J, Cervera R, Pallares L, et al. Infection in systemic lupus erythematosus (SLE): A controlled and prospective study [abstract]. Arthritis Rheum 1990;33:S130.
16. Formiga Perez F, Moga Sampere I, Canet Gonzalez R, et al. Infection and systemic lupus erythematosus: Analysis of a series of 145 patients. Rev Clin Esp 1993;193:105-9.
17. Ginzler E, Diamond H, Kaplan D, et al. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum 1978;21:37-44.
18. Godeau B, Mortier E, Roy PM, et al. Short and longterm outcomes for patients with systemic rheumatic diseases admitted to intensive care units: a prognostic study of 181 patients. J Rheumatol 1997;24:1317-23.
19. Hernandez-Cruz B, Cardiel MH, Villa AR, et al. Development, recurrence, and severity of infections in Mexican patients with rheumatoid arthritis. A nested case-control study. J Rheumatol 1998;25:1900-7.
20. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: An analysis of 158 patients. Ann Intern Med 1992;116:488-98.
21. Inman RD. The role of infection in chronic arthritis. J Rheumatol Suppl 1992;33:98-104.
22. Issacs JD, Greer S, Sharma S, et al. Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia. Arthritis Rheum 2001;44:1998-2008.
23. Janwityanuchit S, Totemchokchyakarn K, Krachangwongchai K, et al. Infection in systemic lupus erythematosus. J Med Assoc Thai 1993;76:542-8.
24. Jonsson H, Nived O, Sturfelt G. Outcome in systemic lupus erythematosus: A prospective study of patients from a defined population. Medicine (Baltimore) 1989;68:141-50.
25. Juega J, Pedreira JD, Adega M, et al. Infection in systemic lupus erythematosus. Rev Clin Esp 1989;184:245-6.
26. Klein NC, Cunha BA. Infections in systemic lupus erythematosus. Infect Dis Clin Pract 1999;8:225.
27. Kollef MH, Enzenauer RJ. Predicting outcome from intensive care for patients with rheumatologic diseases. J Rheumatol 1992;19:1260-2.
28. Lee P, Urowitz MB, Bookman AA, et al. Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis, QJM 1977;46:1-32.
29. Mitchell DM, Spitz PW, Young DY, et al. Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum 1986;29:706-14.
30. Mok CC, Lee KW, Ho CT, et al. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology (Oxford) 2000;39:399-406.
31. Myllykangas-Luosujarvi R, Aho K, Kautiainen H, et al. Shortening of life span and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis. Clin Exp Rheumatol 1995;13:149-53.
32. Noel V, Lortholary O, Casassus P, et al. Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis 2001;60:1141-4.
33. Oh HM, Chng HH, Boey ML, et al. Infections in systemic lupus erythematosus. Singapore Med J 1993;34:406-8.
34. Paton NI. Infections in systemic lupus erythematosus patients. Ann Acad Med Singapore 1997;26:694-700.
35. Peschken CA, Esdaile JM. Systemic lupus erythematosus in North American Indians: A population based study. J Rheumatol 2000;27:1884-91.
36. Petri M. Infection in systemic lupus erythematosus. Rheum Dis Clin North Am 1998;24(2):423-56.
37. Prior P, Symmons DP, Scott DL, et al. Cause of death in rheumatoid arthritis. Br J Rheumatol 1984;23:92-9.
38. Ramey DR, Rausch PI, Schettler JD, et al. Serious infections in rheumatoid arthritis: What is the scope of the problem? [abstract]. Arthritis Rheum 1999;42:S279.
39. Riise T, Jacobsen BK, Gran JT, et al. Total mortality is increased in rheumatoid arthritis. A 17-year prospective study. Clin Rheumatol 2001;20:123-7.
40. Rosner S, Ginzler EM, Diamond HS, et al. A multicenter study of outcome in systemic lupus erythematosus. II. causes of death. Arthritis Rheum 1982;25:612-7.
41. Rubin LA, Urowitz MB, Gladman DD. Mortality in systemic lupus erythematosus: The bimodal pattern revisited. QJM 1985;55:87-98.
42. Shyam C, Malaviya AN. Infection-related morbidity in systemic lupus erythematosus: A clinico-epidemiological study from northern India. Rheumatol Int 1996;16:1-3.
43. Stahl-Hallengren C, Jonsen A, Nived O, et al. Incidence studies of systemic lupus erythematosus in southern Sweden: Increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol 2000;27:685-91.
44. Staples PJ, Gerding DN, Decker JL, et al. Incidence of infection in systemic lupus erythematosus. Arthritis Rheum 1974;17:1-10.
45. Thong BY, Tai DY, Goh SK, et al. An audit of patients with rheumatic disease requiring medical intensive care. Ann Acad Med Singapore 2001;30:254-9.
46. Trager J, Ward MM. Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol 2001;13:345-51.
47. Vandenbroucke JP, Hazevoet HM, Cats A. Survival and cause of death in rheumatoid arthritis: A 25-year prospective followup. J Rheumatol 1984;11:158-61.
48. Ward MM, Pyun E, Studenski S. Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort. Arthritis Rheum 1995;38:1492-9.
49. Wolfe F, Mitchell DM, Sibley JT, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94.
50. Yeap SS, Chow SK, Manivasagar M, et al. Mortality patterns in Malaysian systemic lupus erythematosus patients. Med J Malaysia 2001;56:308-12.
51. Zonana-Nacach A, Camargo-Coronel A, Yanez P, Sanchez L, et al. Infections in outpatients with systemic lupus erythematosus: A prospective study. Lupus 2001;10:505-10.
52. Moore PM, Cupps TR. Neurological complications of vasculitis. Ann Neurol 1983;14:155-67.
53. Mraz-Gernhard SM, Bush TM, Riebman JB. Clinical images: Libman-Sacks endocarditis. Arthritis Rheum 2001;44:2111.
54. Vaughan JH. Infection and rheumatic diseases: A review (2). Bull Rheum Dis 1990;39:1-8.
55. Venables PJ. Infection and rheumatoid arthritis. Curr Opin Rheumatol 1989;1:15-20.
56. Cohen J, Pinching AJ, Rees AJ, et al. Infection and immunosuppression. A study of the infective complications of 75 patients with immunologically-mediated disease. QJM 1982; 51:1-15.
57. Go CHU, Cunha BA. Infections in patients on steroids. Infectious Disease Practice. 2000;24:61.
58. Klein NC, Go CH, Cunha BA. Infections associated with steroid use. Infect Dis Clin North Am 2001;15:423-32.
59. Mikuls TR, Saag KG. Comorbidity in rheumatoid arthritis. Rheum Dis Clin North Am 2001;27:283-303.
60. Segal BH, Sneller MC. Infectious complications of immunosuppressive therapy in patients with rheumatic diseases. Rheum Dis Clin North Am 1997;23:219-37.
61. Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Review of Infectious Diseases 1989;11:954-63.
62. Aboguddah A, Stein HB, Phillips P, et al. Herpes simplex hepatitis in a patient with psoriatic arthritis taking prednisone and methotrexate. Report and review of the literature. J Rheumatol 1991;18:1406-12.
63. Auzary C, Mouthon L, Soilleux M, et al. Localized subcutaneous Nocardiafarcinica abscess in a woman with overlap syndrome between systemic scleroderma and polymyositis. Ann Med Interne (Paris) 1999;150:582-4.
64. Badsha H, Edwards CJ, Chng HH. Melioidosis in systemic lupus erythematosus: The importance of early diagnosis and treatment in patients from endemic areas. Lupus 2001;10:821-3.
65. DiNubile MJ, Albornoz MA, Stumacher RJ, et al. Pneumococcal soft-tissue infections: Possible association with connective tissue diseases. J Infect Dis 1991;163:897-900.
66. Galarza DA, Esquivel-Valerio JA, Navarro G, et al. Prevalence of chlamydia ocular infection in patients with rheumatoid arthritis who are taking glucocorticoids [abstract]. Arthritis Rheum 2001;44:S173.
67. Hellmann DB, Petri M, Whiting-O'Keefe Q. Fatal infections in systemic lupus erythematosus: The role of opportunistic organisms. Medicine (Baltimore) 1987;66:341-8.
68. Kraus A, Cabral AR, Sifuentes-Osornio J, et al. Listeriosis in patients with connective tissue diseases. J Rheumatol 1994;21:635-8.
69. Ognibene FP, Shelhamer JH, Hoffman GS, et al. Pneumocystis carinii pneumonia: A major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. Am J Respir Crit Care Med 1995;151:795-9.
70. Rivera E, Maldonado N, Velez-Garcia E, et al. Hyperinfection syndrome with Strongyloides stercoralis. Ann Intern Med 1970;72:199-204.
71. Scowden EB, Schaffner W, Stone WJ. Overwhelming strongyloidiasis: An unappreciated opportunistic infection. Medicine (Baltimore) 1978;57:527-44.
72. Setoyama M, Fukumaru S, Takasaki T, et al. SLE with death from acute massive pulmonary hemorrhage caused by disseminated strongyloidiasis. Scand J Rheumatol 1997;26:389-91.
73. Van der Straeten C, Wei N, Rothschild J, et al. Rapidly fatal pneumococcal septicemia in systemic lupus erythematosus. J Rheumatol 1987;14:1177-80.
74. Wiggins Jr. RE. Invasive aspergillosis. A complication of treatment of temporal arteritis. J Neuroophthalmol 1995;15:36-8.
75. Wilcox MH, Powell RJ, Pugh SF, et al. Toxoplasmosis and systemic lupus erythematosus. Ann Rheum Dis 1990;49:254-7.
76. Andersen FG, Guckian JC. Systemic lupus erythematosus associated with fatal pulmonary coccidioidomycosis. Tex Rep Biol Med 1968;26:93-9.
77. Balbir-Gurman A, Schapira D, Nahir AM. Primary subcutaneous nocardial infection in a SLE patient. Lupus 1999;8:164-7.
78. Greene R, Kaufman R, Quismorio Jr. FP. Septic bursitis in systemic lupus erythematosus. Clin Rheumatol 1984;3:55-9.
79. Huang JW, Hung KY, Yen CJ, et al. Systemic lupus erythematosus and peritoneal dialysis: Outcomes and infectious complications. Perit Dial Int 2001;21:143-7.
80. Gardner GC, Weisman MH. Pyarthrosis in patients with rheumatoid arthritis: A report of 13 cases and a review of the literature from the past 40 years. Am J Med 1990;88:503-11.
81. Doran MF, Pond GR, Crowson CS, et al. Risk of infection in persons with rheumatoid arthritis compared to controls: A population-based study [abstract]. Arthritis Rheum 2001;44:S105.
82. Mowat AG, Hothersall TE, Gould JC. Urinary tract infection in patients with rheumatoid arthritis. Ann Rheum Dis 1970;29:143-8.
83. Myllykangas-Luosujarvi RA, Aho K, Isomaki HA. Mortality in rheumatoid arthritis. Semin Arthritis Rheum 1995;25:193-202.
84. Rowe IF, Deans AC, Keat AC. Pyogenic infection and rheumatoid arthritis. Postgrad Med J 1987;63:19.
85. Symmons DP, Jones MA, Scott DL, et al. Longterm mortality outcome in patients with rheumatoid arthritis: Early presenters continue to do well. J Rheumatol 1998;25:1072-7.
86. Al-Hadithy H, Isenberg DA, Addison IE, et al. Neutrophil function in systemic lupus erythematosus and other collagen diseases. Ann Rheum Dis 1982;41:33-8.
87. Iliopoulos AG, Tsokos GC. Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Semin Arthritis Rheum 1996;25:318-36.
88. Ng WI, Yuen KY, Chu CM. Lymphopenia at disease presentation predicts major infections in patients with systemic lupus erythematosus [abstract]. Arthritis Rheum 2001;44:S 245.
89. Ehrenfeld M, Urowitz MB, Platts ME. Selective C4 deficiency, systemic lupus erythematosus, and Whipple's disease. Ann Rheum Dis 1984;43:91-4.
90. Dillon AM, Stein HB, English RA. Splenic atrophy in systemic lupus erythematosus. Ann Intern Med 1982;96:40-3.
91. Piliero P, Furie R. Functional asplenia in systemic lupus erythematosus. Semin Arthritis Rheum 1990;20:185-9.
92. Austin III HA, Klippel JH, Balow JE, et al. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 1986;314:614-9.
93. Seror P, Pluvinage P, d'Andre FL, et al. Frequency of sepsis after local corticosteroid injection (an inquiry on 1160000 injections in rheumatological private practice in France). Rheumatology (Oxford) 1999;38:1272-4.
94. Fauci AS, Dale DC. The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J Clin Invest 1974;53:240-6.
95. Butler WT, Rossen RD. Effects of corticosteroids on immunity in man. I. Decreased serum IgG concentration caused by 3 or 5 days of high doses of methylprednisolone. J Clin Invest 1973;52:2629-40.
96. Saag KG, Koehnke R, Caldwell JR, et al. Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events. Am J Med 1994;96:115-23.
97. Williams AJ, Zardawi I, Walls J. Disseminated aspergillosis in high dose steroid therapy. Lancet 1983;1:1222.
98. Wollheim FA. Acute and long-term complications of corticosteroid pulse therapy. Scand J Rheumatol Suppl 1984;54:27-32.
99. Badsha H, Kong KO, Lian TY, et al. Pulse methylprednisolone for SLE flares: A lower dose decreases the risk of serious infection without reducing efficacy [abstract]. Arthritis Rheum 2001;44:S280.
100. Laan RF, van Riel PL, van de Putte LB. Leflunomide and methotrexate. Curr Opin Rheumatol 2001;13:159-63.
101. Sneller MC, Hoffman GS, Talar-Williams C, et al. An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone. Arthritis Rheum 1995; 38:608-13.
102. McCune WJ, Golbus J, Zeldes W, et al. Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. N Engl J Med 1988;318:1423-31.
103. Bradley JD, Brandt KD, Katz BP. Infectious complications of cyclophosphamide treatment for vasculitis. Arthritis Rheum 1989;32:45-53.
104. Kattwinkel N, Cook L, Agnello V. Overwhelming fatal infection in a young woman after intravenous cyclophosphamide therapy for lupus nephritis. J Rheumatol 1991;18:79-81.
105. van der Veen MJ, van der Heide A, Kruize AA, et al. Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate. Ann Rheum Dis 1994;53:224-8.
106. Lang B, Riegel W, Peters T, et al. Low dose methotrexate therapy for rheumatoid arthritis complicated by pancytopenia and Pneumocystis carinii pneumonia. J Rheumatol 1991;18: 1257-9.
107. Smith JD, Knox JM. Psoriasis, methotrexate and tuberculosis. Br J Dermatol 1971;84:590-3.
108. Boerbooms AM, Kerstens PJ, van Loenhout JW, et al Infections during low-dose methotrexate treatment in rheumatoid arthritis. Semin Arthritis Rheum 1995;24:411-21.
109. Perhala RS, Wilke WS, Clough JD, et al. Local infectious complications following large joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate. Arthritis Rheum 1991;34:146-52.
110. Salaffi F, Manganelli P, Carotti M, et al. Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: Report of five cases and review of the literature. Clin Rheumatol 1997;16:296-304.
111. Anderson DJ, Janoff EN. Herpes zoster infection in a patient on methotrexate given prednisone to prevent post-herpetic neuralgia. Ann Intern Med 1987;107:783.
112. Antonelli MA, Moreland LW, Brick JE. Herpes zoster in patients with rheumatoid arthritis treated with weekly, low-dose methotrexate. Am J Med 1991;90:295-8.
113. Altz-Smith M, Kendall Jr. LG, Stamm AM. Cryptococcosis associated with low-dose methotrexate for arthritis. Am J Med 1987;83:179-81.
114. Furst DE, Erikson N, Clute L, et al. Adverse experience with methotrexate during 176 weeks of a longterm prospective trial in patients with rheumatoid arthritis. J Rheumatol 1990;17:1628-35.
115. Gispen JG, Alarcon GS, Johnson JJ, et al. Toxicity of methotrexate in rheumatoid arthritis. J Rheumatol 1987;14:74-9.
116. Jansen TL, van Heereveld HA, Laan RF, et al. Septic arthritis with Listeria monocytogenes during low-dose methotrexate. J Intern Med 1998;244:87-90.
117. Keegan JM, Byrd JW. Nocardiosis associated with low dose methotrexate for rheumatoid arthritis. J Rheumatol 1988;15:1585-6.
118. Krugmann J, Sailer-Hock M, Muller T, et al. Epstein-Barr virus-associated Hodgkin's lymphoma and legionella pneumophila infection complicating treatment of juvenile rheumatoid arthritis with methotrexate and cyclosporine A. Hum Pathol 2000;31:253-5.
119. Wallace JR, Luchi M. Fatal cytomegalovirus pneumonia in a patient receiving corticosteroids and methotrexate for mixed connective tissue disease. South Med J 1996;89:726-8.
120. Witty LA, Steiner F, Curfman M, et al. Disseminated histoplasmosis in patients receiving low-dose methotrexate therapy for psoriasis. Arch Dermatol 1992;128:91-3.
121. Bridges Jr. SL, Lopez-Mendez A, Han KH, et al. Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis? J Rheumatol 1991;18:984-8.
122. Hargreaves MR, Mowat AG, Benson MK. Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: Report of five cases and review of published reports. Thorax 1992;47:628-33.
123. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today 1992;13:136-42.
124. Bathon JM, Martin RW, Fleischmann RM, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000;343:1586-93.
125. US Food and Drug Administration. Criteria for Use of Leflunamide, Etanercept, and Infliximab in the Treatment of Rheumatoid Arthritis. U.S. Food and Drug Administration (Rockville, MD); 2001. Available at: http://vapbm.org/criteria/lef_etan_infcriteria.pdf. Accessed 1 Oct 2001.
126. Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345:1098-104.
127. Lipsky P, St Clair EW, Furst D. 54-week clinical and radiographic results from the ATTRACT trial: A Phase III study of infliximab (Remicade) in patients with active RA despite methotrexate [abstract]. Arthritis Rheum 1999;42(Suppl):S147.
128. Maini R, St Clair EW, Breedveld F, et al. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial. ATTRACT Study Group. Lancet. 1999;354:1932-9.
129. Van den Bosch F, De Keyser F, Joos R, et al. Reactivation of tuberculosis in 2 patients with spondyloarthropathy treated with infliximab (abstract]. Arthritis Rheum 2001;44:S78.
130. Baghai M, Osmon DR, Wolk DM, et al. Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept. Mayo Clin Proc 2001;76:653-6.
131. Belostocki KB, Leibowitz E, Tai K, et al. Infections associated with etanercept treatment of rheumatoid arthritis: 2 Years of experience in the "real-world" [abstract]. Arthritis Rheum 2001;44:S173.
132. Keenan GF, Clark J, Baker DG, et al. The rare occurrence of fungal infections in patients receiving infliximab [abstract]. Arthritis Rheum 2001;44:S82.
133. Wallis WJ, Burge DJ, Sabath D, et al. Tuberculosis reports with etanercept (Enbrel®) therapy [abstract]. Arthritis Rheum 2001;44:S78.
134. Carmona L, Gonzalez-Alvaro I, Sanmarti R, et al. EMECAR Study Group. Rheumatoid arthritis is associated to a four-fold increase in tuberculosis infection incidence in the pre-biologics era [abstract]. Arthritis Rheum 2001;44:S173.
135. Harvey AM, Shulman LE, Tumulty PA, et al. Systemic lupus erythematosus: Review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 1954;33:291-437.
136. Inoue T, Takeda T, Koda S, et al. Differential diagnosis of fever in systemic lupus erythematosus using discriminant analysis. Rheumatol Int 1986;6:69-77.
137. Stahl NI, Klippel JH, Decker JL. Fever in systemic lupus erythematosus. Am J Med 1979;67: 935-40.
138. Kim JS, Lee KS, Koh EM, et al. Thoracic involvement of systemic lupus erythematosus: Clinical, pathologic, and radiologic findings. J Comput Assist Tomogr 2000;24:9-18.
139. Kim WU, Kim SI, Yoo WH, et al. Adult respiratory distress syndrome in systemic lupus erythematosus: Causes and prognostic factors: A single center, retrospective study. Lupus 1999;8:552-7.
140. Donadio Jr. JV, Holley KE, Ferguson RH, et al. Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide. N Engl J Med 1978;299:1151-5.
141. Koch CA, Robyn JA, Coccia MR. Systemic lupus erythematosus: A risk factor for pneumonia caused by Legionella micdadei? Arch Intern Med 1997;157:2670-1.
142. Pohl MA, Lan SP, Berl T. Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. Ann Intern Med 1991;114:924-9.
143. Kraus A, Guerra-Bautista G, Chavarria P. Paragonimiasis: An infrequent but treatable cause of hemoptysis in systemic lupus erythematosus. J Rheumatol 1990;17:244-6.
144. Cheema GS, Quismorio Jr. FP. Interstitial lung disease in systemic lupus erythematosus. Curr Opin Pulm Med 2000;6:424-9.
145. Keane MP, Lynch III JP. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax 2000;55:159-66.
146. Orens JB, Martinez FJ, Lynch III JP. Pleuropulmonary manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am 1994;20:159-93.
147. Prakash UB. Respiratory complications in mixed connective tissue disease. Clin Chest Med 1998;19:733-46.
148. Staudinger T, Roggla M, Kettenbach J, et al. Respiratory failure in systemic lupus erythematosus: Decisive differentiation between acute pneumonitis and infection. Br J Rheumatol 1997;36:295-7.
149. Garrett DO, Jochimsen E, Jarvis W. Invasive Aspergillus spp infections in rheumatology patients. J Rheumatol 1999;26:146-9.
150. Mera JR, Whimbey E, Elting L, et al. Cytomegalovirus pneumonia in adult nontransplantation patients with cancer: Review of 20 cases occurring from 1964 through 1990. Clin Infect Dis 1996;22:1046-50.
151. Nishino H, Rubino FA, DeRemee RA, et al. Neurological involvement in Wegener's granulomatosis: An analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 1993;33:4-9.
152. Zamir D, Amar M, Groisman G, et al. Toxoplasma infection in systemic lupus erythematosus mimicking lupus cerebritis. Mayo Clin Proc 1999;74:575-8.
153. West SG. Neuropsychiatric lupus. Rheum Dis Clin North Am 1994;20:129-58.
154. Wong KL, Woo EK, Yu YL, et al. Neurological manifestations of systemic lupus erythematosus: A prospective study. QJM 1991;81:857-70.
155. Feinglass EJ, Arnett FC, Dorsch CA, et al. Neuropsychiatric manifestations of systemic lupus erythematosus: Diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) 1976;55:323-39.
156. Sibley JT, Olszynski WP, Decoteau WE, et al. The incidence and prognosis of central nervous system disease in systemic lupus erythematosus. J Rheumatol 1992;19:47-52.
157. Suh CH, Jeong YS, Park HC, et al. Risk factors for infection and role of C-reactive protein in Korean patients with systemic lupus erythematosus. Clin Exp Rheumatol 2001;19:191-4.
158. Becker GJ, Waldburger M, Hughes GR, et al. Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus. Ann Rheum Dis 1980;39:50-2.
159. Hind CR, Ng SC, Feng PH, et al. Serum C-reactive protein measurement in the detection of intercurrent infection in Oriental patients with systemic lupus erythematosus. Ann Rheum Dis 1985;44:260-1.
160. Linares LF, Gomez-Reino JJ, Carreira PE, et al. C-reactive protein (CRP) levels in systemic lupus erythematosus (SLE). Clin Rheumatol 1986;5:66-9.
161. ter Borg EJ, Horst G, Limburg PC, et al. C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: A protective longitudinal study. J Rheumatol 1990;17:1642-8.
162. Roy S, Tan KT. Pyrexia and normal C-reactive protein (CRP) in patients with systemic lupus erythematosus: Always consider the possibility of infection in febrile patients with systemic lupus erythematosus regardless of CRP levels. Rheumatology (Oxford) 2001;40:349-50.
163. Liou LB. Serum and in vitro production of IL-1 receptor antagonist correlate with C-reactive protein levels in newly diagnosed, untreated lupus patients. Clin Exp Rheumatol 2001;19: 515-23.
164. Lim MK, Lee CK, Ju YS, et al. Serum ferritin as a serologic marker of activity in systemic lupus erythematosus. Rheumatol Int 2001;20:89-93.
165. Ames PR, Alves J, Pap AF, et al. Fibrinogen in systemic lupus erythematosus: More than an acute phase reactant? J Rheumatol 2000;27:1190-5.
166. Shin KC, Lee YJ, Kang SW, et al. Serum procalcitonin measurement for detection of intercurrent infection in febrile patients with SLE. Ann Rheum Dis 2001;60:988-9.
167. Blanco FJ, Gomez-Reino JJ, de la Mata J, et al. Survival analysis of 306 European Spanish patients with systemic lupus erythematosus. Lupus 1998;7:159-63.
168. Jindal B, Joshi K, Radotra BD, et al. Fatal complications of systemic lupus erythematosusan autopsy study from north India. Indian J Pathol Microbiol 2000;43:311-7.
169. Kim WU, Min JK, Lee SH, et al. Causes of death in Korean patients with systemic lupus erythematosus: A single center retrospective study. Clin Exp Rheumatol 1999;17:539-45.
170. Nived O, Sturfelt G, Wollheim F. Systemic lupus erythematosus and infection: A controlled and prospective study including an epidemiological group. QJM 1985;55:271-87.
171. Caldeira L, Dutschmann L, Carmo G, et al. Fatal Pasteurella multocida infection in a systemic lupus erythematosus patient. Infection 1993;21:254-5.
172. Deleze M, Mintz G, del Carmen Mejia M. Toxoplasma gondii encephalitis in systemic lupus erythematosus. A neglected cause of treatable nervous system infection. J Rheumatol 1985;12:994-6.
173. Goodman SM, Russell L, Kagen L, et al. Fever and pneumonia in a steroid treated patient with systemic lupus erythematosus. Lupus 2000;9:318-21.
174. Rahman P, Gladman DD, Ibanez D, et al. Significance of isolated hematuria and isolated pyuria in systemic lupus erythematosus. Lupus 2001;10:418-23.
175. Clough W, Cassell GH, Duffy LB, et al. Septic arthritis and bacteremia due to Mycoplasma resistant to antimicrobial therapy in a patient with systemic lupus erythematosus. Clin Infect Dis 1992;15:402-7.
176. D'Ercole C, Boubli L, Franck J, et al. Recurrent congenital toxoplasmosis in a woman with lupus erythematosus. Prenat Diagn 1995;15:1171-5.
177. Molnar-Nadasdy G, Haesly I, Reed J, et al. Placental cryptococcosis in a mother with systemic lupus erythematosus. Arch Pathol Lab Med 1994;118:757-9.
178. Nomura S, Hatta K, Iwata T, et al. Legionella pneumophila isolated in pure culture from the ascites of a patient with systemic lupus erythematosus. Am J Med 1989;86:833-4.
179. Senecal JL, St-Antoine P, Beliveau C. Legionella pneumophila lung abscess in a patient with systemic lupus erythematosus. Am J Med Sci 1987;293:309-14.
180. Tai ES, Fong KY. Fatal amoebic colitis in a patient with SLE: A case report and review of the literature. Lupus 1997;6:610-2.
181. Gonzalez-Crespo MR, Gomez-Reino JJ. Invasive aspergillosis in systemic lupus erythematosus. Semin Arthritis Rheum 1995;24:304-14.
182. Abramson S, Kramer SB, Radin A, et al. Salmonella bacteremia in systemic lupus erythematosus. Eight-year experience at a municipal hospital. Arthritis Rheum 1985;28:75-9.
183. Mitchell SR, Nguyen PQ, Katz P. Increased risk of neisserial infections in systemic lupus erythematosus. Semin Arthritis Rheum 1990;20:174-84.
184. Shahram F, Akbarian M, Davatchi F. Salmonella infection in systemic lupus erythematosus. Lupus 1993;2:55-9.
185. Gorevic PD, Katler EI, Agus B. Pulmonary nocardiosis. Occurrence in men with systemic lupus erythematosus. Arch Intern Med 1980;140:361-3.
186. Ishibashi Y, Watanabe R, Hommura S, et al. Endogenous Nocardia asteroides endophthalmitis in a patient with systemic lupus erythematosus. Br J Ophthalmol 1990;74:433-6.
187. Mok CC, Lau CS, Poon SP. Primary nocardial meningitis in systemic lupus erythematosus. Br J Rheumatol 1995;34:178-81.
188. Mok CC, Lau CS, Yuen KY. Cryptococcal meningitis presenting concurrently with systemic lupus erythematosus. Clin Exp Rheumatol 1998;16:169-71.
189. Petri M, Katzenstein P, Hellmann D. Laryngeal infection in lupus: Report of nocardiosis and review of laryngeal involvement in lupus. J Rheumatol 1988;15:1014-5.
190. Zimmermann III B, Spiegel M, Lally EV. Cryptococcal meningitis in systemic lupus erythematosus. Semin Arthritis Rheum 1992;22:18-24.
191. Shatley MJ, Walker BL, McMurray RW. Lues and lupus: Syphilis mimicking systemic lupus erythematosus (SLE). Lupus 2001;10:299-303.
192. Pryor BD, Bologna SG, Kahl LE. Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 1996;39:1475-82.
193. Yuhara T, Takemura H, Akama T, et al. Predicting infection in hospitalized patients with systemic lupus erythematosus. Intern Med 1996;35:29-36.
194. Gaubitz M, Herrmann M, Shahin M, et al. Cat scratch disease (bartonellosis) mimicking an SLE flare. Lupus 2001;10:883-5.
195. Huang YC, Lin YT, Yang YH, et al. Acute lupus pneumonitis mimicking pulmonary tuberculosis: A case report. J Microbiol Immunol Infect 2001;34:143-6.
196. Navarrete MG, Brey RL. Neuropsychiatric systemic lupus erythematosus. Current Treatment Options in Neurology 2000;2:473-85.
197. Ruggieri AP. Neuropsychiatric lupus: Nomenclature, classification, criteria, and other confusional states. Arthritis Rheum 2001;45:406-9.
198. Gaylis NB, Altman RD, Ostrov S, Quencer R. The selective value of computed tomography of the brain in cerebritis due to systemic lupus erythematosus. J Rheumatol 1982;9:850-4.
199. Harisdangkul V, Songcharoen S, Lin AC. Listerial infections in patients with systemic lupus erythematosus. South Med J 1992;85:957-60.
200. Huseyin TS, Maynard JP, Leach RD. Toxic shock syndrome in a patient with breast cancer and systemic lupus erythematosus. Eur J Surg Oncol 2001;27:330-1.
201. Petros D, West S. Overwhelming pneumococcal bacteraemia in systemic lupus erythematosus. Ann Rheum Dis 1989;48:333-5.
202. Mackenzie AR, Laing RB, MacDonald AG, et al. Pneumococcal septicaemia in a patient with systemic lupus erythematosus. Ann Rheum Dis 1997;56:403-4.
203. Shalit M, Gross DJ, Levo Y. Pneumococcal epiglottitis in systemic lupus erythematosus on high-dose corticosteroids. Ann Rheum Dis 1982;41:615-6.
204. Webster J, Williams BD, Smith AP, et al. Systemic lupus erythematosus presenting as pneumococcal septicaemia and septic arthritis. Ann Rheum Dis 1990;49:181-3.
205. Boey ML, Feng PH. Salmonella infection in systemic lupus erythematosus. Singapore Med J 1982;23:147-51.
206. Chen JY, Luo SF, Wu YJ, et al. Salmonella septic arthritis in systemic lupus erythematosus and other systemic diseases. Clin Rheumatol 1998;17:282-7.
207. Pablos JL, Aragon A, Gomez-Reino JJ. Salmonellosis and systemic lupus erythematosus. Report of ten cases. Br J Rheumatol 1994;33:129-32.
208. Shamiss A, Thaler M, Nussinovitch N, et al. Multiple Salmonella enteritidis leg abscesses in a patient with systemic lupus erythematosus. Postgrad Med J 1990;66:486-8.
209. Lim E, Koh WH, Loh SF, et al. Non-typhoidal salmonellosis in patients with systemic lupus erythematosus. A study of fifty patients and a review of the literature. Lupus 2001;10:87-92.
210. Lovy MR, Ryan PF, Hughes GR. Concurrent systemic lupus erythematosus and salmonellosis. J Rheumatol 1981;8:605-12.
211. van de Laar MA, Meenhorst PL, van Soesbergen RM, et al. Polyarticular Salmonella bacterial arthritis in a patient with systemic lupus erythematosus. J Rheumatol 1989;16:231-4.
212. Frayha RA, Jizi I, Saadeh G. Salmonella typhimurium bacteriuria. An increased infection rate in systemic lupus erythematosus. Arch Intern Med 1985;145:645-7.
213. Picillo U. Italian G, Marcialis MR, et al. Bilateral femoral osteomyelitis with knee arthritis due to Salmonella enteritidis in a patient with systemic lupus erythematosus. Clin Rheumatol 2001;20:53-6.
214. Sanchez-Guerrero J, Alarcon-Segovia D. Salmonella pericarditis with tamponade in systemic lupus erythematosus. Br J Rheumatol 1990;29:69-71.
215. Li EK, Cohen MG, Ho AK, et al. Salmonella bacteremia occurring concurrently with the first presentation of systemic lupus erythematosus. Br J Rheumatol 1993;32:66-7.
216. Medina F, Fraga A, Lavalle C. Salmonella septic arthritis in systemic lupus erythematosus. The importance of chronic carrier state. J Rheumatol 1989;16:203-8.
217. Carratala J, Moreno R, Cabellos C, et al. Neisseria meningiditis monoarthritis revealing systemic lupus erythematosus. J Rheumatol 1988;15:532-3.
218. Feliciano R, Swedler W, Varga J. Infection with uncommon subgroup Y Neisseria meningitidis in patients with systemic lupus erythematosus. Clin Exp Rheumatol 1999;17:737-40.
219. Lehman TJ, Bernstein B, Hanson V, et al. Meningococcal infection complicating systemic lupus erythematosus. J Pediatr 1981;99:94-6.
220. Tikly M, Diese M, Zannettou N, et al. Gonococcal endocarditis in a patient with systemic lupus erythematosus. Br J Rheumatol 1997;36:270-2.
221. Turner-Stokes L, Isenberg DA. Immunisation of patients with rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 1988;47:529-31.
222. Kim HA, Yoo CD, Baek HJ, et al. Mycobacterium tuberculosis infection in a corticosteroidtreated rheumatic disease patient population. Clin Exp Rheumatol 1998;16:9-13.
223. Kim HY, Im JG, Goo JM, et al. Pulmonary tuberculosis in patients with systematic lupus erythematosus. AJR Am J Roentgenol 1999;173:1639-42.
224. Tam LS, Li, EK, Szeto CC. Tuberculosis in Chinese patients with systemic lupus erythematosus [abstract]. Arthritis Rheum 2001;44:S245.
225. Victorio-Navarra STG, Arroyo CG, Torralba TP. Tuberculosis among Filipino patients with systemic lupus erythematosus. Lupus 1995;4(S2):89.
226. Belzunegui J, Plazaola I, Uriarte E, et al. Primary tuberculous muscle abscess in a patient with systemic lupus erythematosus. Br J Rheumatol 1995;34:1177-8.
227. Berker M, Atalay B, Soylemezoglu F, et al. Cervical tuberculous spondylitis associated with systemic lupus erythematosus. Spinal Cord 2001;39:549-53.
228. Uthman I, Bizri AR, Hajj AR, et al. Miliary tuberculosis presenting as tenosynovitis in a case of rheumatoid arthritis. J Infect 1998;37:196-8.
229. Feng PH, Tan TH. Tuberculosis in patients with systemic lupus erythematosus. Ann Rheum Dis 1982;41:11-4.
230. Hernandez-Cruz B, Sifuentes-Osornio J, Ponce-de-Leon Rosales S, et al. Mycobacterium tuberculosis infection in patients with systemic rheumatic diseases. A case-series. Clin Exp Rheumatol 1999;17:289-96.
231. Czelusta A, Moore AY. Cutaneous Mycobacterium kansasii infection in a patient with systemic lupus erythematosus: Case report and review. J Am Acad Dermatol 1999;40:359-63.
232. Glickstein SL, Nashel DJ. Mycobacterium kansasii septic arthritis complicating rheumatic disease: Case report and review of the literature. Semin Arthritis Rheum 1987;16:231-5.
233. Nakamura T, Yamamura Y, Tsuruta T, et al. Mycobacterium kansasii arthritis of the foot in a patient with systemic lupus erythematosus. Intern Med 2001;40:1045-9.
234. Sarrot-Reynauld F, Massot C, Dupre A. Ileo-caecal tuberculosis in systemic lupus erythematosus. Lupus 1995;4(S2):88.
235. Zvetina JR, Demos TC, Rubinstein H. Mycobacterium intracellulare infection of the shoulder and spine in a patient with steroid-treated systemic lupus erythematosus. Skeletal Radiol 1982;8:111-3.
236. Kruyswijk MR, Keuning JJ. Cutaneous cryptococcosis in a patient receiving immunosuppressive drugs for systemic lupus erythematosus. Dermatologica 1980;161:280-4.
237. Nenoff P, Horn LC, Mierzwa M, et al. Peracute disseminated fatal Aspergillus fumigatus sepsis as a complication of corticoid-treated systemic lupus erythematosus. Mycoses 1995;38: 467-71.
238. Pillay VK, Wilson DM, Ing TS, et al. Fungus infection in steroid-treated systemic lupus erythematosus. JAMA 1968;205:261-5.
239. Sato M, Saku N, Takeda A, et al. A case report - pulmonary cryptococcosis associated with systemic lupus erythematosus and review of 44 cases in Japan. Ryumachi 1993;33:56-62.
240. Collazos J, Martinez E, Flores M, et al. Aspergillus pneumonia successfully treated with itraconazole in a patient with systemic lupus erythematosus. Clin Investig Med 1994;72:920-1.
241. Fingerote RJ, Seigel S, Atkinson MH, et al. Disseminated zygomycosis associated with systemic lupus erythematosus. J Rheumatol 1990;17:1692-4.
242. Hansen KE, St Clair EW. Disseminated histoplasmosis in systemic lupus erythematosus: Case report and review of the literature. Semin Arthritis Rheum 1998;28:193-9.
243. Katz A, Ehrenfeld M, Livneh A., et al. Aspergillo in systemic lupus erythematosus. Semin Arthritis Rheum 1996;26:635-40.
244. Lo CY, Chan DT, Yuen KY, et al. Penicillium marneffei infection in a patient with SLE. Lupus 1995;4:229-31.
245. Sawada M, Isogai S, Miyake S, et al. Pulmonary pseudallescherioma associated with systemic lupus erythematosus. Intern Med 1998;37:1046-9.
246. Sieving RR, Kauffman CA, Watanakunakorn C. Deep fungal infection in systemic lupus erythematosus - Three cases reported, literature reviewed. J Rheumatol 1975;2:61-72.
247. Yorgin PD, Rewari M, al-Uzri AY, et al. Coccidioidomycosis in adolescents with lupus nephritis. Pediatr Nephrol 2001;16:77-81.
248. Chayakul P, Thammakumpee G, Mitarnun W. Lung cavities from Pneumocystis carinii in a patient with systemic lupus erythematosus. J Med Assoc Thai 1991;74:310-2.
249. Fortenberry JD, Shew ML. Fatal Pneumocystis carinii in an adolescent with systemic lupus erythematosus. J Adolesc Health Care 1989;10:570-2.
250. Liam CK, Wang F. Pneumocystis carinii pneumonia patients with systemic lupus erythematosus. Lupus 1992;1:379-85.
251. Page B. Pneumocystis carinii pneumonia and systemic lupus erythematosus. Lupus 1995;4:89.
252. Porges AJ, Beattie SL, Ritchlin C. Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia. J Rheumatol 1992;19:1191-4.
253. Sharma CP, Chaudhary D, Behera D. Pneumocystis carinii pneumonia in a patient with active untreated systemic lupus erythematosus. Indian J Chest Dis Allied Sci 2001;43:169-71.
254. Tsai HC, Lee SS, Lin HH, et al. Pneumocystis carinii pneumonia in systemic lupus erythematosus: A report of two cases. J Formos Med Assoc 2001;100:699-702.
255. Gerrard JG. Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults. Med J Aust 1995;162:233-5.
256. Kadoya A, Okada J, Iikuni Y, et al. Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis/dermatomyositis or systemic lupus erythematosus. J Rheumatol 1996;23:1186-8.
257. Ward MM, Donald F. Pneumocystis carinii pneumonia in patients with connective tissue diseases: The role of hospital experience in diagnosis and mortality. Arthritis Rheum 1999;42:780-9.
258. Godeau B, Coutant-Perronne V, Le Thi Huong D, et al. Pneumocystis carinii pneumonia in the course of connective tissue disease: Report of 34 cases. J Rheumatol 1994;21:246-51.
259. Permin H, Aldershvile J, Nielsen JO. Hepatitis B virus infection in patients with rheumatic diseases. Ann Rheum Dis 1982;41:479-82.
260. Ramos-Casals M, Font J, Garcia-Carrasco M, et al. Hepatitis C virus infection mimicking systemic lupus erythematosus: Study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus. Arthritis Rheum 2000;43:2801-6.
261. Kahl LE. Herpes zoster infections in systemic lupus erythematosus: Risk factors and outcome. J Rheumatol 1994;21:84-6.
262. Kang TY, Jun JB, Jung S, et al. Herpes zoster infection in patients with systemic lupus erythematosus [abstract]. Arthritis Rheum 2001;44:S245.
263. Moga I, Formiga F, Canet R, et al. Herpes-zoster virus infection in patients with systemic lupus erythematosus. Rev Clin Esp 1995;195:530-3.
264. Bendiksen S, Van Ghelue M, Rekvig OP, et al. A longitudinal study of human cytomegalovirus serology and viruria fails to detect active viral infection in 20 systemic lupus erythematosus patients. Lupus 2000;9:120-6.
265. Rider JR, Ollier WE, Lock RJ, et al. Human cytomegalovirus infection and systemic lupus erythematosus. Clin Exp Rheumatol 1997;15:405-9.
266. Vasquez V, Barzaga RA, Cunha BA. Cytomegalovirus-induced flare of systemic lupus erythematosus. Heart Lung 1992;21:407-8.
267. Dror Y, Blachar Y, Cohen P, et al. Systemic lupus erythematosus associated with acute Epstein-Barr virus infection. Am J Kidney Dis 1998;32:825-8.
268. Hayashi T, Lee S, Ogasawara H, et al. Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection. Lupus 1998;7:561-4.
269. Krueger GR, Sander C, Hoffmann A, et al. Isolation of human herpesvirus-6 (HHV-6) from patients with collagen vascular diseases. In Vivo 1991;5:217-25.
270. Tokunaga Y, Takenaka K, Asayama R, et al. Cytomegalovirus-induced interstitial pneumonitis in a patient with systemic lupus erythematosus. Intern Med 1996;35:517-20.
271. Vilaichone RK, Mahachai V, Eiam-Ong S, et al. Necrotizing ileitis caused by cytomegalovirus in patient with systemic lupus erythematosus: Case report. J Med Assoc Thai 2001;84(Suppl 1):S469-73.
272. Fox RA, Isenberg DA. Human immunodeficiency virus infection in systemic lupus erythematosus. Arthritis Rheum 1997;40:1168-72.
273. Newton P, Aldridge RD, Lessells AM, et al. Progressive multifocal leukoencephalopathy complicating systemic lupus erythematosus. Arthritis Rheum 1986;29:337-43.
274. Ferri C, Zakrzewska K, Longombardo G, et al. Parvovirus B19 infection of bone marrow in systemic sclerosis patients. Clin Exp Rheumatol 1999;17:718-20.
275. Vigeant P, Menard HA, Boire G. Chronic modulation of the autoimmune response following parvovirus B19 infection. J Rheumatol 1994;21:1165-7.
276. Hsu TC, Tsay GJ. Human parvovirus B19 infection in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2001;40:152-7.
277. Narvaez Garcia FJ, Domingo-Domenech E, Castro-Bohorquez FJ, et al. Lupus-like presentation of parvovirus B19 infection. Am J Med 2001;111:573-5.
278. Caramaschi P, Zeminian S, Carletto A, et al. Parvovirus B19 infection and rheumatic diseases. Rev Rhum Engl Ed 1996;63:846-53.
279. Chassagne P, Mejjad O, Gourmelen O, et al. Exacerbation of systemic lupus erythematosus during human parvovirus B19 infection. Br J Rheumatol 1993;32:158-9.
280. Nigro G, Piazze J, Taliani G, et al. Postpartum lupus erythematosus associated with parvovirus B19 infection. J Rheumatol 1997;24:968-70.
281. van Albada-Kuipers GA, Linthorst J, Peeters EA, et al. Frequency of infection among patients with rheumatoid arthritis versus patients with osteoarthritis or soft tissue rheumatism. Arthritis Rheum 1988;31:667-71.
282. Vandenbroucke JP, Kaaks R, Valkenburg HA, et al. Frequency of infections among rheumatoid arthritis patients, before and after disease onset. Arthritis Rheum 1987;30:810-3.
283. Goldenberg DL. Infectious arthritis complicating rheumatoid arthritis and other chronic rheumatic disorders. Arthritis Rheum 1989;32:496-502.
284. Mateo Soria L, Miquel Nolla Sole J, Rozadilla Sacanell A, et al. Infectious arthritis in patients with rheumatoid arthritis. Ann Rheum Dis 1992;51:402-3.
285. Mitchell WS, Brooks PM, Stevenson RD, et al. Septic arthritis in patients with rheumatoid disease: A still underdiagnosed complication. J Rheumatol 1976;3:124-33.
286. Nolla JM, Gomez-Vaquero C, Fiter J, et al. Pyarthrosis in patients with rheumatoid arthritis: A detailed analysis of 10 cases and literature review. Semin Arthritis Rheum 2000;30:121-6.
287. Sharma M, Leirisalo-Repo M. Arthritis patient as an emergency case at a university hospital. Scand J Rheumatol 1997;26:30-6.
288. Dubost JJ, Fis I, Soubrier M, et al. Septic arthritis in rheumatoid arthritis. A review of twenty-four cases of the medical literature. Revue du Rhumatisme Edition Francaise 1994; 61:143-65.
289. Kellgren J, Ball J, Fairbrother R, et al. Suppurative arthritis complicating rheumatoid arthritis. BMJ 1958;1:1193.
290. Kraft SM, Panush RS, Longley S. Unrecognized aphylococcal pyarthrosis with rheumatoid arthritis. Semin Arthritis Rheum 1985;14:196-201.
291. Barth WF, Healey LA, Decker JL. Septic arthritis due to Pasteurella multocida complicating rheumatoid arthritis. Arthritis Rheum 1968;11:394-9.
292. Campen DH, Kaufman RL, Beardmore TD. Candida septic arthritis in rheumatoid arthritis. J Rheumatol 1990;17:86-8.
293. Dodd MJ, Griffiths ID, Freeman R. Pyogenic arthritis due to bacteroides complicating rheumatoid arthritis. Ann Rheum Dis 1982;41:248-9.
294. Duyur B, Erdem HR, Ozgocmen S. Paravertebral abscess formation and knee arthritis due to brucellosis in a patient with rheumatoid arthritis. Spinal Cord 2001;39:554-6.
295. Gordon DL, Philpot CR, McGuire C. Plesiomonas shigelloides septic arthritis complicating rheumatoid arthritis. Aust N Z J Med 1983;13:275-6.
296. Gruberg L, Thaler M, Rozenman J, et al. Nocardia asteroides infection complicating rheumatoid arthritis. J Rheumatol 1991;18:459-61.
297. Iwata H, Kinoshita M, Sumiya M, et al. Emergence of erosive polyarthritis coincident with Mycobacterium kansasii pulmonary infection in a patient with systemic sclerosis-rheumatoid arthritis overlap syndrome. Clin Exp Rheumatol 1999;17:757-8.
298. Jeansson S, Kvien TK. Acanthamoeba polyphaga in rheumatoid arthritis: Possibility for a chronic infection. Scand J Immunol 2001;53:610-4.
299. Brzeski M, Smart L, Baird D, et al. Pneumococcall septic arthritis after splenectomy in Felty's syndrome. Ann Rheum Dis 1991;50:724-6.
300. Gonzalez-Gay MA, Fernandez Camblor B, Varela E, et al. Septic arthritis from Streptococcus pneumoniae in rheumatoid arthritis. An Med Interna 1992;9:312.
301. Lohse A, Despaux J, Auge B, et al. Pneumococcal polyarticular septic arthritis in a patient with rheumatoid arthritis. Rev Rhum Engl Ed 1999;66:344-6.
302. Blackburn Jr. WD, Dunn TL, Alarcon GS. Infection versus disease activity in rheumatoid arthritis: Eight years' experience. South Med J 1986;79:1238-41.
303. Cornelissen JJ, Bakker LJ, Van der Veen MJ, et al. Nocardia asteroides pneumonia complicating low dose methotrexate treatment of refractory rheumatoid arthritis. Ann Rheum Dis 1991;50:642-4.
304. Walker WC. Pulmonary infections and rheumatoid arthritis. QJM 1967;36:239-51.
305. Flood DA, Chan CK, Pruzanski W. Pneumocystis carinii pneumonia associated with methotrexate therapy in rheumatoid arthritis. J Rheumatol 1991;18:1254-6.
306. Perruquet JL, Harrington TM, Davis DE. Pneumocystis carinii pneumonia following methotrexate therapy for rheumatoid arthritis. Arthritis Rheum 1983;26:1291-2.
307. Roux N, Flipo RM, Cortet B, et al. Pneumocystis carinii pneumonia in rheumatoid arthritis patients treated with methotrexate. A report of two cases. Rev Rhum Engl Ed 1996;63:453-6.
308. Watkin SW, Bucknall RC, Nisar M, et al. Atypical mycobacterial infection of the lung in rheumatoid arthritis. Ann Rheum Dis 1989;48:336-8.
309. Wolfe F, Flowers N, Anderson J, et al. Tuberculosis rates are not increased in rheumatoid arthritis [abstract]. Arthritis Rheum 2001;44:S105.
310. Elkayam O, Paran D, Caspi D, et al. Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus. Clin Infect Dis 2002;34:147-53.
311. Ioannou Y, Isenberg DA. Immunisation of patients with systemic lupus erythematosus: The current state of play. Lupus 1999;8:497-501.